<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease is a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo>, multisystem <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disorder</z:e>; vascular involvement has been considered to result from systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, which most frequently affects veins and occurs in 5% to 10% of these patients </plain></SENT>
<SENT sid="1" pm="."><plain>However, superior vena cava (SVC) involvement is rare; it accounts for only 6% of the cases </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this article is to a report on a case of SVC recanalization through the use of fibrinolysis and self-expanding stents as treatment of life-threatening SVC syndrome in a young male patient with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease </plain></SENT>
</text></document>